Changes in TDS, H/M ratio, and WR of patients in valsartan and enalapril groups
| Valsartan | Enalapril | |||
|---|---|---|---|---|
| Baseline | 6 months | Baseline | 6 months | |
| Values are mean (SD). | ||||
| *p<0.01 v baseline; **p<0.05 v baseline. | ||||
| 123I-MIBG | ||||
| TDS | 43 (8) | 39 (10)* | 43 (9) | 42 (10) |
| H/M ratio | 1.70 (0.17) | 1.78 (0.22)** | 1.68 (0.36) | 1.67 (0.22) |
| WR | 46 (11) | 41 (10)** | 47 (8) | 46 (10) |